Completed NA INTERVENTIONAL 2-arm NCT01852162

Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy

Pharmacodynamic Effects of Dabigatran in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel

Sponsor: University of Florida

Conditions Coronary Artery Disease

Interventions Dabigatran Placebo

Updated 5 times since 2017 Last updated: Mar 10, 2015 Started: Feb 29, 2012 Primary completion: Jan 31, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by University of Florida and has accumulated 5 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Florida

Data source: University of Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jacksonville, United States